SciELO - Scientific Electronic Library Online

 
vol.30 suppl.5Correlation among the evaluation by APACHE-II system, renal function evolution and survival of critical patientsST segment regression: a prognostic indicator of reperfusion in the acute myocardial infarction author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

  • Have no cited articlesCited by SciELO

Related links

  • Have no similar articlesSimilars in SciELO

Share


Revista Cubana de Medicina Militar

Print version ISSN 0138-6557On-line version ISSN 1561-3046

Abstract

PADRON SANCHEZ, Armando; BRAVO PEREZ, Rigoberto; PUGA TORRES, Mario Santiago  and  JOANES FIOL, Javier. Door-drug interval. Rev Cub Med Mil [online]. 2001, vol.30, suppl.5, pp.41-46. ISSN 0138-6557.

Sixty-seven patients with acute myocardial infarction were studied, who had been applied a streptokinase-based thrombolytic treatment in the Emergency service of “Dr Luis Díaz Soto” Higher Institute of Military Medicine. The sample was divided into 2 groups: those who receive thrombolytics within 6 hours of the onset of symptoms (group A) and those who received them after 6 hours (group B). This variable was called door-drug interval. The objective was to define how the door-drug interval influences on the course and complication of the acute myocardial infarction. The group A patients had less mechanical complications and heart failure, more supraventricular arrhythmias and the difference of ST segment regression was higher, but their progression was more favorable than that of the group B patients. It is concluded that the use of thrombolytic therapy in the acute myocardial infarction should begin as soon as possible to reduce risks of future complications.

Keywords : MYOCARDIAL INFARCTION [drug therapy]; FIBRINOLYTIC AGENTS [therapeutic use]; INTENSIVE CARE UNITS.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License